TScan Therapeutics, Inc.

TScan Therapeutics, Inc.

TCRX
TScan Therapeutics, Inc.US flagNASDAQ
0.94
USD
+0.02
- -
57.43MMarket Cap

Income Statement (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
1
10
14
21
3
10
+ Sales & Services Revenue
- -
1
10
14
21
3
10
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
-1
-10
-14
-21
-3
-10
- Operating Expenses
14
27
59
80
115
138
146
+ Selling, General & Admin
5
7
14
20
25
30
31
+ Research & Development
9
21
45
60
88
107
114
+ Other Operating Expense
- -
- -
- -
- -
1
1
1
Operating Income (Loss)
-14
-26
-49
-67
-93
-135
-136
- Non-Operating (Income) Loss
-1
- -
- -
- -
-4
-7
-6
+ Interest Expense, Net
-1
- -
- -
- -
-4
-8
-6
+ Interest Expense
- -
- -
- -
1
4
4
3
- Interest Income
1
- -
- -
2
8
12
9
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
1
- -
Pretax Income
-14
-26
-49
-66
-89
-127
-130
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-14
-26
-49
-66
-89
-127
-130
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-14
-26
-49
-66
-89
-127
-130
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-14
-26
-49
-66
-89
-127
-130
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-14
-26
-49
-66
-89
-127
-130
EBIT
-14
-26
-49
-67
-93
-135
-136
EBITDA
-14
-25
-45
-61
-88
-131
-133
EBITDA Margin (%)
- -
-2,304.42
-446.83
-454.37
-418.53
-4,641.8
-1,287.62
EBITA
-14
-26
-49
-67
-93
-135
-136
Gross Margin (%)
- -
100
100
100
100
100
100
Operating Margin (%)
- -
-2,417.79
-479.65
-492.32
-444
-4,787.68
-1,315.38
Profit Margin (%)
- -
-2,408.02
-479.49
-489.26
-423.86
-4,527.66
-1,256.81
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
1
1
3
5
5
4
3
Basic Weighted Avg Shares
24
24
12
24
66
112
130
Basic EPS, GAAP
-0.57
-1.09
-4.17
-2.75
-1.36
-1.14
-1
Basic EPS from Cont Ops
-0.57
-1.09
-4.17
-2.75
-1.36
-1.14
-1
Diluted Weighted Avg Shares
24
24
12
24
66
112
130
Diluted EPS, GAAP
-0.57
-1.09
-4.17
-2.75
-1.36
-1.14
-1
Diluted EPS from Cont Ops
-0.57
-1.09
-4.17
-2.75
-1.36
-1.14
-1

Balance Sheet (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
42
36
166
124
194
293
157
+ Cash, Cash Equivalents & STI
42
35
161
120
192
290
152
+ Cash & Cash Equivalents
42
35
161
120
133
179
152
+ ST Investments
- -
- -
- -
- -
59
111
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
1
2
4
4
2
3
5
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
7
13
22
75
78
78
72
+ Property, Plant & Equip, Net
6
13
17
69
71
72
66
+ Property, Plant & Equip
7
14
22
79
86
90
88
- Accumulated Depreciation
1
2
5
10
15
19
22
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
1
1
5
6
7
7
5
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
1
1
5
6
7
7
5
Total Assets
49
50
188
199
272
371
229
+ Payables & Accruals
1
4
5
5
7
13
5
+ Accounts Payable
1
3
2
3
2
4
1
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
1
3
2
5
8
3
+ ST Debt
- -
1
2
4
7
5
7
+ ST Borrowings
- -
- -
- -
- -
3
- -
- -
+ ST Finance Leases
- -
1
2
4
3
5
7
+ Other ST Liabilities
1
12
15
9
16
19
7
+ Deferred Revenue
- -
11
11
4
10
12
3
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
1
2
4
5
6
7
4
Total Current Liabilities
2
17
21
17
30
36
19
+ LT Debt
4
6
4
82
86
93
87
+ LT Borrowings
- -
- -
- -
29
27
32
33
+ LT Finance Leases
4
6
4
53
59
61
54
+ Other LT Liabilities
60
69
2
- -
6
1
- -
+ Accrued Liabilities
- -
9
1
- -
6
1
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
60
60
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
64
75
6
82
91
94
87
Total Liabilities
67
92
27
100
121
130
106
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
1
253
258
398
616
628
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
1
253
258
398
616
628
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-17
-44
-92
-158
-248
-375
-505
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-17
-42
161
99
151
241
123
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
Total Equity
-17
-42
161
99
151
241
123
Total Liabilities & Equity
49
50
188
199
272
371
229
Shares Outstanding
24
24
24
24
48
57
57
Number of Employees
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
5
7
6
57
62
65
62
Net Debt
-42
-35
-161
-91
-103
-147
-120
Net Debt to Equity
243.69
81.93
-100.39
-91.25
-68.48
-60.84
-97.36
Tangible Common Equity Ratio
-34.7
-85.37
85.47
49.94
55.44
64.93
53.82
Current Ratio
17.69
2.09
7.76
7.17
6.51
8.14
8.41
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-14
-26
-49
-66
-89
-127
-130
+ Depreciation & Amortization
1
1
3
5
5
4
3
+ Non-Cash Items
- -
1
3
5
5
8
10
+ Stock-Based Compensation
- -
1
3
5
5
10
12
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
- -
- -
- -
- -
-2
-2
+ Chg in Non-Cash Work Cap
- -
21
-6
-10
18
5
-18
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-1
-3
- -
1
-1
-1
+ Inc (Dec) in Accts Payable
1
3
3
1
4
7
-10
+ Inc (Dec) in Other
- -
20
-7
-11
13
-1
-7
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-13
-3
-49
-67
-61
-111
-135
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-1
-4
-10
-4
-3
-4
-4
+ Acq of Fixed Prod Assets
-1
-4
-10
-4
-3
-4
-4
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
90
- -
42
33
- -
+ Increase in Capital Stock
- -
- -
90
- -
42
33
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
-58
-49
114
+ Dec in LT Investment
- -
- -
- -
- -
20
193
201
+ Inc in LT Investment
- -
- -
- -
- -
-78
-241
-87
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
-1
-4
-10
-4
-61
-53
109
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
29
- -
15
- -
+ Cash From Debt
- -
- -
- -
29
- -
32
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
-17
- -
+ Other Financing Activities
35
- -
100
- -
93
160
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
35
- -
190
29
135
209
- -
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
21
-7
131
-41
13
45
-26
EBITDA
-14
-25
-45
-61
-88
-131
-133
EBITDA Margin (%)
- -
-2,304.42
-446.83
-454.37
-418.53
-4,641.8
-1,287.62
Free Cash Flow
-14
-7
-59
-71
-65
-115
-140
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-7
-59
-41
-65
-99
-140
Free Cash Flow per Basic Share
-0.58
-0.3
-5.03
-2.94
-0.98
-1.02
-1.08
Price/Free Cash Flow
- -
- -
-1.35
-0.6
-6.57
-3.18
-0.99
Cash Flow to Net Income
0.92
0.12
1
1
0.69
0.87
1.04
Capital Expenditures
-1
-4
-10
-4
-3
-4
-4